학술논문

337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study
Document Type
Abstract
Source
In Annals of Oncology September 2020 31 Supplement 4:S382-S382
Subject
Language
ISSN
0923-7534